Research report: Runway Growth Finance Corp. (NASDAQ: RWAY)

We are short Runway Growth Finance Corp. (NASDAQ: RWAY) because, in our opinion, Runway Growth Finance Corporation (“Runway”, “Runway Growth”, “RWAY”) is misleading shareholders and lacking transparency, as discrepancies in their disclosed loan-to-value (LTV) ratio and actual figures raise concerns. Furthermore, the company’s reliance on high-risk payment-in-kind (PIK) loans, coupled with significant cash shortfalls and a decline in loan originations, jeopardizes its dividend strategy and long-term viability.

In our opinion,

  • RWAY claims a low LTV of 17% compared to industry averages, but the actual LTV is significantly higher at 24%. This is not disclosed in any regulatory filings, indicating potential inaccuracies and a lack of transparency. RWAY is deceiving shareholders by not fully disclosing the risk of an investment in the company’s stock. Runway Growth’s valuation methods for investments are highly subjective and circumvented SEC rules, specifically Rule 2a-5. We believe the manipulated fair value of investments like Pivot3, Gynesonics, Marley Spoon, and Circadence raises concerns about the reliability and accuracy of RWAY’s financial statements.
  • RWAY’s significant share of high-risk PIK loans and the increase in PIK interest income by 760% within the last two years raise doubts about the availability of sufficient cash support. The company’s distribution of cash dividends exceeding its net investment income, reaching a ratio of 121% in Q1/23, indicates a significant shortfall of cash. This leads to potential challenges in fulfilling future dividend obligations and raises concerns about the long-term sustainability of RWAY’s dividend strategy.
  • In the first half of 2023, Runway Growth experienced a notable decline in its deal flow, resulting in significantly fewer loan originations compared to analysts’ expectations. The company’s performance was characterized by lackluster originations, leading to net repayments of $35 million instead of $280 million in net originations. Furthermore, additional repayments have been communicated by RWAY’s borrowers, which will result in a cash loss of total investment income amounting to $13.4 million annually until 2026.
  • Runway Growth heavily relies on consistent net originations to generate interest income and support dividend payments. The stalled originations also highlight the shift towards a portfolio of high-risk payment-in-kind (PIK) loans from distressed late-stage growth companies, posing additional risks for investors.
  • Runway’s investment in Pivot3 Holdings raises concerns due to the concealment of Pivot3’s liquidation and the inclusion of “ghost value” on RWAY’s balance sheet. Despite the sale of Pivot3’s assets below book value of the loan principal, Runway Growth recorded a realized gain instead of a loss in 2021. Pivot3 ceased operations in June 2021 and RWAY’s continuous classification of Pivot3 loans as non-accrual, coupled with its marked-up fair value, suggest an attempt to offset other investments’ unrealized losses to whitewash RWAY’s net income.
  • Runway Growth’s investment in Gynesonics, a biotech company, raises concerns due to RWAY’s failure to promptly disclose Gynesonics’ restructuring and the subsequent conversion of 50% of the senior secured loans into unsecured preferred equity. The lack of transparency and failure to assign a higher risk rating accurately demonstrate RWAY’s manipulated risk assessment, mismanagement, and disregard for shareholder interests. The swap into riskier equity positions, after previous equity holders were wiped out, puts Runway Growth at significant losses because Gynesonics’ equity was marked down by 13% in the first 30 days of ownership. The preferred equity’s rapid fair value deterioration and the limited growth prospects of Gynesonics indicate a high likelihood of complete loss on the investment.
  • RWAY’s loans to Marley Spoon, a distressed meal delivery company, exceed the portfolio company’s current market capitalization, indicating a risky investment with doubtful repayment prospects. Marley Spoon’s financial distress, negative equity, and significant cash burn rate raise concerns about the reported fair value of the loans. Despite Marley Spoon undergoing a restructuring through a de-SPAC merger with a German company, accompanied by significant alterations of the financial covenants, such as amortization and maturity extensions, and PIK relief, Runway Growth’s risk rating for Marley Spoon has not changed. We believe there is a likelihood of another ill-advised debt-to-equity swap, potentially resulting in worthless Marley Spoon stock and losses for Runway Growth’s shareholders.
  • Runway’s loans to Circadence Corporation, a government contractor specializing in educational products, have experienced substantial fair value markdowns, with a 99% reduction in the accompanying equity stake. Since 2014, Circadence struggled in securing new government contracts and according to government documents its remaining backlog is only worth $1.4 million. Because the loans are PIK interest-only loans with SOFR+9.50% PIK, we believe the fair value is highly overstated and Circadence will be unable to repay its loan with cash.
  • Investments with an aggregated principal of more than $140 million are in distress or bankruptcy-like status and RWAY failed to disclose material information about several investments. In addition, the portfolio becomes more concentrated towards distressed PIK loans as healthy cash-generative companies repay their loans early while RWAY’s deal flow stalled within the first half of 2023.

Legal disclaimer

By downloading from or viewing material on this website you agree to the following Terms and Conditions. Use of NINGI Research’s (“NINGI”, “we”, “our”) research is at your own risk. In no event should we or any affiliated party be liable for any direct or indirect trading losses caused by any information on this website. You further agree to do your own research and due diligence, consult your own financial, legal, and tax advisors before making any investment decision with respect to transacting in any securities covered herein. You should assume that, as of the date of our publications, we (possibly along with or through our members, partners, affiliates, and/or employees) have a direct or indirect short position in any security (including equity securities, options, swaps, other derivative securities, debt securities and/or CFD) covered herein and therefore stand to realize monetary gains in the event that the price of stock moves. We (possibly along with or through our members, partners, affiliates, and/or employees) intend to continue transacting in any security covered herein or mentioned in connection to our publications and may be long, short, and/or neutral at any time after the date of the publication regardless of our initial position and/or recommendation. Every document, information, data, analysis, and statement on this website and/or in our publications is expressed for educational purposes only and is expressed as an opinion, not a statement of fact. To the best of our ability and belief, all materials contained on this website or in any publication are accurate and reliable. All statements are based on a strict due diligence process, but all information on this website and/or in our publications is provided “as is” without warranties of any kind. We explicitly do not take responsibility and/or warranty with respect to the fitness of the information for any usage. Any statements are expressed as our personal opinions in a public forum, and our opinions consolidate the information of our own analysis. All materials on this website and/or in our publications are subject to any change without further notice. We expressed our opinion based on public information available in the respective jurisdiction. Any cited information based on a uniform resource locator is available through its respective URL on the date of the publication. We do not take any responsibility and/or warranty for the future availability of any cited information. None of the materials herein, in any of our publications, on this website, and/or any communication regarding this website and/or any of our publications should be considered an offer to sell or a solicitation of an offer to buy any security or investment product, nor do we intend to make any such an offer, nor shall any security be offered or sold to any person, in any jurisdiction in which such offer would be unlawful under the securities laws of such jurisdiction, nor as investment advice or a recommendation to buy or sell any investment products or to make any type of investment, or as an opinion on the merits or otherwise of any particular investment or investment strategy. Please seek the advice of a registered security professional regarding any transaction or investment decision in your jurisdiction. NINGI Research is not a licensed or registered investment advisor in any jurisdiction. Any trading strategy or investment strategy mentioned, stated, or discussed on this website or/and in our publications is expressed for educational purposes only. Historical performance is not indicative of the future performance of any security or investment product. We do not take any responsibility and are in no event liable for any direct or indirect financial losses of any kind regarding any statements, figures, analysis, conclusions, or opinions stated, on this website, in our publications, or in connection with our publications or our website. We do not take part in any insider trading, and we do not use any material non-public information in our report or in any other publications. Any cited source can be accessed in the respective jurisdiction and was already publicly available before the distribution of our publications. If any provision in these terms is held to be invalid or unenforceable, then the remaining provisions shall continue in full force and effect.

We publish in-depth research about public companies. Don’t miss out on our latest reports. Sign up now!